(R) -1-[3,5-Bis(trifluoromethyl)phenyl]ethanol CAS 127852-28-2 Puritas >99.0%

Description:

(R) -1-[3,5-Bis(trifluoromethyl)phenyl]ethanol

CAS: 127852-28-2

Puritas: >99.0% (GC)

Aspectus: Alba ad Off-White pulveris

Intermedia Aprepitantis (CAS: 170729-80-3)

High Quality, Commercial Production

Mobile/Wechat/Whatsapp: +86-15026746401

E-Mail: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Ducens manufacturer ac elit
Intermedia Aprepitantis (CAS: 170729-80-3)
4-Benzyl-2-Hydroxymorpholin-3-one CAS 287930-73-8
(R) -1-[3,5-Bis(trifluoromethyl)phenyl]ethanol CAS 127852-28-2
Please contact: alvin@ruifuchem.com

Chemical Properties:

Nomen chemicum	(R) -1-[3,5-Bis(trifluoromethyl)phenyl]ethanol
Synonyma	(R) -1-[3,5-Bis(trifluoromethyl)phenyl]ethyl Alcohol;(R) -3,5-Bis (trifluoromethyl) -α-Methylbenzyl
CAS Number	127852-28-2
CATTUS Number	RF-CC302
Stock Status	In Stock, Productio Ascendite ad Tons
Formulae hypotheticae	C10H8F6O
M. Pondus	258.16
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Alba ad Off-White pulveris
Puritas / Analysis Methodus	>99.0% (GC)
Liquescens punctum	53.0~ 57.0℃
Optical gyrationis	+26.0° ~ +29.0° (C=1 IN Acetonitrile)
Infrared Imaginis	Conformat ut Structure
Test Standard	Enterprise Standard
Consuetudinem	Intermedia Aprepitantis (CAS: 170729-80-3)

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore

commoda:

FAQ:

Applicatio:

(R) -1-[3,5-Bis(trifluoromethyl)phenyl]ethanol (CAS: 127852-28-2) is used ut medium pharmaceuticum, synthesis chiralis pro reactionibus organicis, Aprepitant (CAS: 170729-80-3) media.Aprepitans est compositum chemicum antiemeticum.Aprepitantis adhibetur ad praecavendam acutam et retardatam chemotherapylam nauseam et vomitum (CINV) et ad praecavendam nauseam et vomitum postoperativam.Primum feliciter a Merck Company (German).Mense Martio MMIII, US Cibus et medicamentum Administration approbavit ut usus in curatione chemotherapy vomitus esset.